| Net Cash Provided by (Used in) Operating Activities |
$4,198,000 |
USD |
20% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$6,304,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
40,322,320 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,111,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$12,483,000 |
USD |
-35% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$57,812,000 |
USD |
3.6% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$58,995,000 |
USD |
3.3% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$589,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Depreciation |
$80,000 |
USD |
19% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$50,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$364,000 |
USD |
39% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$631,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$803,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$313,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$318,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$313,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$42,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$28,181,000 |
USD |
-0.51% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$4,789,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$373,602,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |